Gerresheimer (ETR:GXI) has been assigned a €55.00 ($67.90) price target by stock analysts at Hauck & Aufhaeuser in a research note issued on Tuesday. The brokerage presently has a “sell” rating on the stock. Hauck & Aufhaeuser’s target price points to a potential downside of 17.23% from the stock’s current price.

Several other equities research analysts have also commented on the company. Berenberg Bank set a €75.00 ($92.59) price objective on Gerresheimer and gave the stock a “buy” rating in a research note on Friday, December 8th. Deutsche Bank set a €64.00 ($79.01) price objective on Gerresheimer and gave the stock a “neutral” rating in a research note on Thursday, October 12th. Credit Suisse Group set a €80.00 ($98.77) price objective on Gerresheimer and gave the stock a “buy” rating in a research note on Tuesday, October 10th. Goldman Sachs Group set a €69.50 ($85.80) price objective on Gerresheimer and gave the stock a “neutral” rating in a research note on Thursday, October 12th. Finally, Kepler Capital Markets set a €65.00 ($80.25) price objective on Gerresheimer and gave the stock a “sell” rating in a research note on Friday, November 3rd. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of €71.61 ($88.41).

Gerresheimer (ETR:GXI) opened at €66.45 ($82.04) on Tuesday. Gerresheimer has a 52 week low of €59.97 ($74.04) and a 52 week high of €78.25 ($96.60). The firm has a market capitalization of $2,070.00 and a PE ratio of 47.13.

TRADEMARK VIOLATION WARNING: “Hauck & Aufhaeuser Reiterates €55.00 Price Target for Gerresheimer (GXI)” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.dailypolitical.com/2018/02/07/hauck-55-00-price-target-for-gerresheimer-gxi.html.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.